News Article
BREAKING RESEARCH NEWS: Stem-Cell Generated Thymus Tissue to Catalyze New Treatments for Transplantation, Type 1 Diabetes and Other Autoimmune Diseases

UCSF Diabetes Center researchers Matthias Hebrok, PhD, and Mark Anderson, MD, PhD, have created in their labs the first functioning human thymus tissue derived from embryonic stem cells – a huge step forward in producing new cell therapies to treat numerous diseases including type 1 diabetes.
Interested in Type 1 Diabetes research? We are interested in you!
UCSF Diabetes Center offers intervention clinical trials for people with type 1 diabetes, as well as prevention studies for relatives of type 1 diabetes patients. Take the type 1 diabetes online screener to see if you or family members are eligible. More information HERE.
Study Challenges Chromium Therapy for the Treatment of Insulin Resistance
UCSF endocrinologist Umesh Masharani and his colleagues have dispelled a commonly held belief that chromium supplements improve insulin sensitivity and help prevent and treat diabetes.
Stopping the Inflammatory Response in Type 2 Diabetes
Diabetes Center investigator Suneil Koliwad, MD, PhD, is exploring how nutritional factors may stimulate tissue inflammation and increase the risk for developing type 2 diabetes. Dr.
Coaxing Human Stem Cells into Insulin-Producing Beta Cells
Center Director Matthias Hebrok, PhD, and his lab colleagues have optimized existing culture conditions to increase the number of pancreas progenitor cells and insulin-producing cells from human stem cells. Their current studies indicate that they are getting closer to generating functional beta cells for transplantation purposes.
Prevention Trials in Progress; New TrialNet Affiliates on Board
With two type 1 diabetes prevention trials currently underway, it is important for blood relatives of those with type 1 diabetes to be tested for autoantibodies that may predict future onset of disease. <TrialNet Information for Relatives>
Faculty Member to Direct Medical Scientist Training Program
Diabetes Center researcher and endocrinologist Mark Anderson, MD, PhD, was recently named the new director of the UCSF Medical Scientist Training Program (MSTP).
New Faculty Member Recruited to UCSF
We'd like to introduce you to a new member of the Diabetes Center, Srinath Sanda, MD. Dr. Sanda received his undergraduate degree at UC San Diego, his medical degree at UC Davis, and completed his residency training in internal medicine and pediatrics at Cedars Sinai Medical Center in LA. He then went on to complete a pediatric endocrinology fellowship at UC San Diego where he worked in the immunology laboratory of Dr. Matthias von Herrath.
